Literature DB >> 16990802

Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood.

Jonathan N W N Barker1, Colin N A Palmer, Yiwei Zhao, Haihui Liao, Peter R Hull, Simon P Lee, Michael H Allen, Simon J Meggitt, Nicholas J Reynolds, Richard C Trembath, W H Irwin McLean.   

Abstract

Atopic dermatitis (AD) is a common disease with a complex etiology in childhood and adult life. A significant proportion of childhood AD is transient, but in many cases it persists into adulthood. We have recently shown that null mutations in the filaggrin gene (FLG) are an important predisposing factor for childhood eczema and eczema-associated asthma, but persistence to adulthood has not been analyzed. Here we studied a cohort of adult patients with persistent AD, which had been present since early childhood. In this cohort, the combined allele frequency of the two common FLG null variants was 0.270 (cf. population frequency 0.046). This represents an odds ratio of 7.7 with 95% confidence interval of 5.3-10.9 and a chi2 P-value of 1.7 x 10(-53). Our data conclusively demonstrate that identification of FLG null alleles is an indicator of a poor prognosis in AD, predisposing to a form of eczema that starts in early infancy and persists into adulthood. This study helps to further define the nature of the AD phenotype associated with FLG null alleles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990802     DOI: 10.1038/sj.jid.5700587

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  77 in total

Review 1.  Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies.

Authors:  Jocelyn M Biagini Myers; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2010-08-24       Impact factor: 4.406

Review 2.  Evolutionary impact of transposable elements on genomic diversity and lineage-specific innovation in vertebrates.

Authors:  Ian A Warren; Magali Naville; Domitille Chalopin; Perrine Levin; Chloé Suzanne Berger; Delphine Galiana; Jean-Nicolas Volff
Journal:  Chromosome Res       Date:  2015-09       Impact factor: 5.239

Review 3.  Eczema in pregnancy.

Authors:  Sophie Weatherhead; Stephen C Robson; Nick J Reynolds
Journal:  BMJ       Date:  2007-07-21

Review 4.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

Review 5.  Management of atopic eczema in children aged up to 12 years: summary of NICE guidance.

Authors:  Sue Lewis-Jones; Moira A Mugglestone
Journal:  BMJ       Date:  2007-12-15

Review 6.  Systemic treatment of adult atopic dermatitis.

Authors:  Hannah Cookson; Catherine Smith
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

7.  Skin barrier defects in atopic dermatitis.

Authors:  Rachana Agrawal; Judith A Woodfolk
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

Review 8.  The influence of skin microorganisms on cutaneous immunity.

Authors:  Yasmine Belkaid; Samira Tamoutounour
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 9.  The skin microbiome: current perspectives and future challenges.

Authors:  Yiyin Erin Chen; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2013-03-13       Impact factor: 11.527

10.  Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children.

Authors:  S J Brown; C L Relton; H Liao; Y Zhao; A Sandilands; W H I McLean; H J Cordell; N J Reynolds
Journal:  Br J Dermatol       Date:  2009-06-11       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.